Show simple item record

dc.contributor.authorFaerron Guzmán, Carlos A
dc.contributor.authorMontero-Zamora, Pablo
dc.contributor.authorBolaños-Palmieri, Carolina
dc.contributor.authorAraya-Amador, Juliana
dc.contributor.authorBenavides-Rawson, Jorge
dc.contributor.authorÁvila-Agüero, María L
dc.date.accessioned2021-12-02T19:28:54Z
dc.date.available2021-12-02T19:28:54Z
dc.date.issued2021-10-15
dc.identifier.urihttp://hdl.handle.net/10713/17257
dc.description.abstractSince 2020, the COVID-19 pandemic has had a significant impact on morbidity and mortality around the world. As one of the most successful and cost-effective health interventions for preventing infectious diseases, immunization against SARS-CoV-2, is at the moment the most effective strategy for controlling the current pandemic. Despite the high vaccine acceptance rates that countries such as Costa Rica have shown in the past, the public acceptance of the COVID-19 vaccine is still uncertain. The purpose of this study was to examine adults' willingness to get a novel COVID-19 vaccine and its potential predictors in Costa Rica. We conducted a cross-sectional study comprising a sample of 4717 adult participants living in Costa Rica who participated in a voluntary electronic survey regarding their intent to get a future COVID-19 vaccine. Results suggest that a high percentage (86.1%) of Costa Ricans aged 18 or more would be willing to be vaccinated once a safe and effective vaccine is approved and distributed in the country. Some relevant significant predictors of willingness to get a COVID-19 vaccine in Costa Rica were higher income, being male, work in the health care sector, and having a relative or a close acquaintance diagnosed with COVID-19. Our findings suggest that it is essential to concentrate efforts on the immediate development of culturally appropriate communication, dissemination, and implementation strategies to maximize immunization against SARS-CoV-2 in Costa Rica.en_US
dc.description.urihttps://doi.org/10.7759/cureus.18798en_US
dc.language.isoenen_US
dc.publisherCureus, Inc.en_US
dc.relation.ispartofCureusen_US
dc.rightsCopyright © 2021, Faerron Guzmán et al.en_US
dc.subjectattitudesen_US
dc.subjectcosta ricaen_US
dc.subjectcovid-19en_US
dc.subjecthesitancyen_US
dc.subjectimmunizationen_US
dc.subjectpandemicen_US
dc.titleWillingness to Get a COVID-19 Vaccine and Its Potential Predictors in Costa Rica: A Cross-Sectional Studyen_US
dc.typeArticleen_US
dc.identifier.doi10.7759/cureus.18798
dc.identifier.pmid34796075
dc.source.volume13
dc.source.issue10
dc.source.beginpagee18798
dc.source.endpage
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record